Companies / Abeona Therapeutics Inc.
Abeona Therapeutics Inc.
Nasdaq: ABEOCIK 318306CLEVELAND, OH
Financials · FY2025
Ownership
57.2M shares outstanding · as of Aug 10, 2026
Ownership
| Insiders | 6.76% | 3,866,387 |
| 10%+ / strategic | 10.57% | 6,043,629 |
| Institutions | 73.40% | 41,971,959 |
| Public float | 9.27% | 5,302,042 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 12
View all →| Insider | % of shares | Shares |
|---|---|---|
Seshadri VishwasCEOChief Executive Officer · Director | 2.50% | 1,430,423 |
Vazzano Joseph WalterChief Financial Officer | 0.99% | 567,775 |
O'Malley Brendan M.SVP, Chief Legal Officer | 0.79% | 451,134 |
Vasanthavada MadhavChief Commercial Officer | 0.56% | 318,619 |
Amoroso MichaelDirector | 0.38% | 217,779 |
Charles Faith L.Director | 0.31% | 176,407 |
Alland LeilaDirector | 0.30% | 173,614 |
Wuchterl Donald A.Director | 0.29% | 167,935 |
Silverstein Christine BerniDirector | 0.24% | 137,722 |
Zeiher Bernhardt GDirector | 0.15% | 84,458 |
Institutional holders 109
View all →| Holder | Value | % of shares |
|---|---|---|
| $26.16M | 8.68% | |
| $20.72M | 5.86% | |
| $18.46M | 5.22% | |
| $14.53M | 4.82% | |
| $14.10M | 4.68% | |
| $13.18M | 4.37% | |
| $10.22M | 2.89% | |
| $9.71M | 3.22% | |
| $6.43M | 1.82% | |
| $5.53M | 1.84% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | Seshadri Vishwas CEO | Sell | Common Stock | $372.3K | -70K -4.56% | 1,460,408 2.55% of shares | medium |
| Mar 31, 2026 | Seshadri Vishwas CEO | Sell | Common Stock | $131.5K | -30K -2.05% | 1,430,423 2.50% of shares | medium |
| Feb 2, 2026 | Silverstein Christine Berni Director | Sell | Common Stock | $102.2K | -20K -12.72% | 137,722 0.24% of shares | medium |
| Jan 22, 2026 | Vazzano Joseph Walter Executive | Sell | Common Stock | $99.5K | -19K -3.18% | 568,560 0.99% of shares | low |
| Feb 2, 2026 | Alland Leila Director | Sell | Common Stock | $92.0K | -18K -9.42% | 173,614 0.30% of shares | low |
| Feb 2, 2026 | Crombez Eric Director | Sell | Common Stock | $82.9K | -16K -20.42% | 63,456 0.11% of shares | low |
| Feb 2, 2026 | Wuchterl Donald A. Director | Sell | Common Stock | $75.4K | -15K -8.11% | 167,935 0.29% of shares | low |
| Jan 22, 2026 | O'Malley Brendan M. Executive | Sell | Common Stock | $72.4K | -14K -2.92% | 451,134 0.79% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Adage Capital Management, L.P. | Passive13G/A | — |
| Daniel Kaufman | Passive13G | — |
| Orin Hirschman | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ABEO | — | 00289Y206 |